» Articles » PMID: 34377364

Insights into the Molecular Mechanism of Positive Cooperativity Between Partial Agonist MK-8666 and Full Allosteric Agonist AP8 of HGPR40 by Gaussian Accelerated Molecular Dynamics (GaMD) Simulations

Overview
Specialty Biotechnology
Date 2021 Aug 11
PMID 34377364
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of human free fatty acid receptor 1 (FFAR1, also called hGPR40) enhances insulin secretion in a glucose-dependent manner. Hence, the development of selective agonist targeting hGPR40 has been proposed as a therapeutic strategy of type 2 diabetes mellitus. Some agonists targeting hGPR40 were reported. The radioligand-binding studies and the crystal structures reveal that there are multiple sites on GPR40, and there exists positive binding cooperativity between the partial agonist MK-8666 and full allosteric agonist (AgoPAM) AP8. In this work, we carried out long-time Gaussian accelerated molecular dynamics (GaMD) simulations on hGPR40 to shed light on the mechanism of the cooperativity between the two agonists at different sites. Our results reveal that the induced-fit conformational coupling is bidirectional between the two sites. The movements and rotations of TM3, TM4, TM5 and TM6 due to their inherent flexibility are crucial in coupling the conformational changes of the two agonists binding sites. These helices adopt similar conformational states upon alternative ligand or both ligands binding. The Leu138, Leu186 and Leu190 play roles in coordinating the rearrangements of residues in the two pockets, which makes the movements of residues in the two sites like gear movements. These results provide detailed information at the atomic level about the conformational coupling between different sites of GPR40, and also provide the structural information for further design of new agonists of GPR40. In addition, these results suggest that it is necessary by considering the effect of other site bound in structure-based ligands discovery.

Citing Articles

A non-canonical mechanism of GPCR activation.

Powers A, Khan A, Paggi J, Latorraca N, Souza S, Di Salvo J Nat Commun. 2024; 15(1):9938.

PMID: 39550377 PMC: 11569127. DOI: 10.1038/s41467-024-54103-6.


Influence of the Water Model on the Structure and Interactions of the GPR40 Protein with the Lipid Membrane and the Solvent: Rigid versus Flexible Water Models.

Aguilar-Pineda J, Gonzalez-Melchor M J Chem Theory Comput. 2024; 20(14):6369-6387.

PMID: 38991114 PMC: 11270832. DOI: 10.1021/acs.jctc.4c00571.


Molecular Mechanism of Phosphorylation-Mediated Impacts on the Conformation Dynamics of GTP-Bound KRAS Probed by GaMD Trajectory-Based Deep Learning.

Chen J, Wang J, Yang W, Zhao L, Zhao J, Hu G Molecules. 2024; 29(10).

PMID: 38792177 PMC: 11123822. DOI: 10.3390/molecules29102317.


Mechanistic Insights into Peptide Binding and Deactivation of an Adhesion G Protein-Coupled Receptor.

Adediwura V, Miao Y Molecules. 2024; 29(1).

PMID: 38202747 PMC: 10780249. DOI: 10.3390/molecules29010164.


Mechanistic insights into the role of calcium in the allosteric regulation of the calmodulin-regulated death-associated protein kinase.

Li X, Li B, Li J, Yang M, Bai Y, Chen K Front Mol Biosci. 2023; 9:1104942.

PMID: 36601586 PMC: 9806222. DOI: 10.3389/fmolb.2022.1104942.


References
1.
Leifke E, Naik H, Wu J, Viswanathan P, Demanno D, Kipnes M . A multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel GPR40 agonist, TAK-875, in subjects with type 2 diabetes. Clin Pharmacol Ther. 2012; 92(1):29-39. DOI: 10.1038/clpt.2012.43. View

2.
Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W . Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013; 27(3):221-34. DOI: 10.1007/s10822-013-9644-8. View

3.
Briscoe C, Peat A, McKeown S, Corbett D, Goetz A, Littleton T . Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol. 2006; 148(5):619-28. PMC: 1751878. DOI: 10.1038/sj.bjp.0706770. View

4.
Haffemayer B, Richard E, Mattras H, Marie J . Functional role of the conserved proline in helix 6 of the human bradykinin B2 receptor. Biochem Biophys Res Commun. 2007; 366(4):1001-6. DOI: 10.1016/j.bbrc.2007.12.069. View

5.
Srivastava A, Yano J, Hirozane Y, Kefala G, Gruswitz F, Snell G . High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875. Nature. 2014; 513(7516):124-7. DOI: 10.1038/nature13494. View